Date: 12-Oct-2019

GSK joins other drugmakers recalling Zantac products

GlaxoSmithKline has decided that stopping distribution of its Zantac products just wont cut it. The U.K. company has decided it is time to pull the ranitidine heartburn meds off of retail shelves. The U.K.s Medicines and Healthcare products Regulatory Agency Tuesday said GSK informed it that is recalling all unexpired Zantac prescription meds from pharmacies due to possible contamination with an impurity N-nitrosodimethylamine (NDMA) which has genotoxic and carcinogenic potential.